Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN87845776Phase 2Completed
Phase 2, open-label, single-arm trial of dabigatran, sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Dabigatran presence in plasma and breast milk at 10 hours. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN87845776.